Pharma industry’s deal value decreases by 76.8 per cent in April 2022
The industry reported 113 Venture Capital (VC) deals worth $2.6 billion in April 2022, compared to the last 12-month average…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
GlobalData Report
Bipolar disorder market to see only modest growth due to persistent generic erosion: GlobalData
GlobalData’s latest report identifies that while there are many established products that can effectively manage acute manic…
Pharma industry reports 53 deals worth $9.6 billion in November 2021: GlobalData
The industry reported 105 venture capital (VC) deals worth $4.2 billion in November 2021, compared to the last 12-month average…
Industry reports 48 deals worth $3 billion in Oct 2021: GlobalData
The healthcare industry reported 91 venture capital (VC) deals worth $2.7 billion in October 2021, compared to the last 12-month…
Pharma industry reports 105 deals worth $27 billion in September
The pharma industry reported 104 venture capital (VC) deals worth $3.5 billion in September 2021, compared to the last 12-month…
COVID-19 shapes Indian pharma deals landscape, reveals GlobalData report
Between 2019 and 2020, the deal number increased by 22 per cent, likely triggered by the COVID-19 pandemic
Deal value in pharma industry decreases by 67.2 per cent in August: Globalata
The industry reported 109 venture capital (VC) deals worth $4.5 billion in August 2021, compared to the last 12-month average of…
37 M&A deals worth $18.9 bn in Aug 2019: GlobalData Report
Amgen’s proposed acquisition of Otezla from Celgene for $13.4 billion provides 71 per cent to deal value